Quadrivalent Influenza vaccine (Split virion, inactivated)
Quadrivalent Influenza Vaccine (split virion, inactivated) is indicated for the prevention of influenza disease caused by the two influenza A virus subtypes and the two influenza B virus types contained in the vaccine for: - active immunisation of adults, including pregnant women, and children from 6 months of age and older, - passive protection of infant(s) from birth to less than 6 months of age following vaccination of pregnant women (see Sections 4.4, 4.6 and 5.1). The use of Quadrivalent Influenza Vaccine (split virion, inactivated) should be based on official recommendations.